Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Third COVID-19 vaccine dose for people with multiple sclerosis who did not seroconvert following two doses of BBIBP-CorV (Sinopharm) inactivated vaccine: A pilot study on safety and immunogenicity.
Front Immunol. 2023 Feb 21;14:952911. doi: 10.3389/fimmu.2023.952911. eCollection 2023.
Front Immunol. 2023.
PMID: 36895555
Free PMC article.
SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: Same story, different vaccine.
Etemadifar M, Sedaghat N, Nouri H, Lotfi N, Chitsaz A, Khorvash R, Zolfaghari H, Ghasemi Movaghar A, Pourabbas M, Salari M.
Etemadifar M, et al. Among authors: ghasemi movaghar a.
Mult Scler Relat Disord. 2022 Jan;57:103417. doi: 10.1016/j.msard.2021.103417. Epub 2021 Nov 22.
Mult Scler Relat Disord. 2022.
PMID: 34875487
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.